Latest filing published 03 Sept 2026 for Teladoc Health, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam C. Vandervoort (senior executive) discloses dealings in 2 companies, chiefly Teladoc Health, Inc. and Independence Holding Co. The record holds 213 filings, for trades running from 13 May 2014 to 2 September 2026.
On the open market, the record shows 1 purchase worth €17k and 58 sales worth €24.0M. The net balance comes to €24.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 149 option exercises. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 3 September 2026 with an option exercise in Teladoc Health, Inc. The last insider purchase was made public on 13 May 2014, 4,546 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations